12.44
price up icon6.23%   0.73
pre-market  Vorhandelsmarkt:  12.26   -0.18   -1.45%
loading

Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten

pulisher
Jun 18, 2025

Analysts Conflicted on These Healthcare Names: Align Tech (ALGN), Nurix Therapeutics (NRIX) and Thermo Fisher (TMO) - The Globe and Mail

Jun 18, 2025
pulisher
Jun 17, 2025

Nurix Therapeutics (NRIX) to Participate in Key Oppenheimer Conf - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Nurix Therapeutics (NRIX) to Participate in Key Oppenheimer Conference | NRIX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

NuCana (NRIX) to Participate in Key Oppenheimer Conference | NRIX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

(NRIX) Investment Analysis - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 14, 2025

Nurix Therapeutics (NASDAQ:NRIX) Trading Down 5.9%Here's What Happened - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Nurix Therapeutics’ SWOT analysis: promising BTK degrader stock faces challenges - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 14, 2025

Nurix Therapeutics’ SWOT analysis: promising BTK degrader stock faces challenges By Investing.com - Investing.com South Africa

Jun 14, 2025
pulisher
Jun 13, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NRIX Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $30.18 Average PT from Brokerages - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Nurix Therapeutics (NRIX) Shares Dip After Trial Update on Bexob - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Nurix stock drops on new trial data for lead drug (NRIX:NASDAQ) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Transcript : Nurix Therapeutics, Inc.Special Call - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Nurix Therapeutics Announces Positive Phase 1 Trial Results - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

NRIX: Promising Data from Nurix's Bexobrutideg Clinical Trial | - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

NRIX: Promising Data from Nurix's Bexobrutideg Clinical Trial | NRIX Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chroni - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenströ - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Breakthrough: Nurix Cancer Drug Achieves Complete Response in Hard-to-Treat Blood Cancers, New Trial Data Shows - Stock Titan

Jun 12, 2025
pulisher
Jun 11, 2025

Nurix Therapeutics reports new KLHDC2 inhibitors - BioWorld MedTech

Jun 11, 2025
pulisher
Jun 10, 2025

Truist Financial Sticks to Its Buy Rating for Nurix Therapeutics (NRIX) - The Globe and Mail

Jun 10, 2025
pulisher
Jun 06, 2025

Nurix Therapeutics, Inc. to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg Being Presented At the 30Th European Hematology Association Congress - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Nurix Therapeutics to Host a Webcast Conference Call to Discuss - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025) - The Manila Times

Jun 06, 2025
pulisher
Jun 06, 2025

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congr - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Nurix Therapeutics to Host Webcast on Phase 1 Clinical Trial Data for Bexobrutideg (NX-5948) at EHA2025 - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 ... - Bluefield Daily Telegraph

Jun 06, 2025
pulisher
Jun 06, 2025

Bexobrutideg Phase 1 Trial Shows Promise in Blood Cancer Treatment at EHA Congress | NRIX Stock News - Stock Titan

Jun 06, 2025
pulisher
Jun 06, 2025

Nurix Therapeutics (NASDAQ:NRIX) Shares Gap UpHere's Why - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Stifel Maintains Buy Rating on Nurix (NRIX) Stock - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last? - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Two Sigma Investments LP - MarketBeat

Jun 04, 2025
pulisher
Jun 03, 2025

(NRIX) On The My Stocks Page - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 03, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Position Reduced by Nuveen Asset Management LLC - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

Sanofi exercises option to license STAT6 program from Nurix collaboration - BioWorld MedTech

Jun 03, 2025
pulisher
Jun 02, 2025

Nurix Therapeutics Stock Climbs as Sanofi Extends License for STAT6 - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi Exercises Exclusive License for Nurix Therapeutics' STAT6 Program - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi Exercises License Extension Option To Nurix'S Stat6 Program - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi Licenses Nurix's STAT6 Program, Enhancing Drug Collaborat - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi Licenses Nurix's STAT6 Program, Enhancing Drug Collaboration | NRIX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi Exercises License Extension Option to Nurix's STAT6 Program | NRIX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Nurix secures additional $15 million from Sanofi license deal - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Nurix Therapeutics Secures $15 Million License Extension from Sanofi for STAT6 Program - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi Bets Big on Nurix: $465M Deal for Revolutionary Inflammation Drug That Could Transform Asthma Treatment - Stock Titan

Jun 02, 2025
pulisher
Jun 01, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Wellington Management Group LLP - MarketBeat

Jun 01, 2025
pulisher
Jun 01, 2025

Nurix Therapeutics (NASDAQ:NRIX) Trading Up 3.9%Time to Buy? - MarketBeat

Jun 01, 2025
pulisher
May 30, 2025

Millennium Management LLC Has $7.99 Million Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 30, 2025
pulisher
May 28, 2025

Twinbeech Capital LP Sells 35,683 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Nurix Therapeutics to Participate in the Jefferies Global Health - GuruFocus

May 28, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):